Nanoparticle: a promising player in nanomedicine and its theranostic applications for the treatment of cardiovascular diseases

S Saeed, SRU Din, SU Khan, R Gul, FA Kiani… - Current Problems in …, 2023 - Elsevier
Cardiovascular diseases (CVDs) are the leading cause of death around the world, a trend
that will progressively grow over the next decade. Recently, with the advancement of …

Recent developments in nanomaterials-based drug delivery and upgrading treatment of cardiovascular diseases

NA Mohamed, I Marei, S Crovella… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

JH Park, D Dehaini, J Zhou, M Holay, RH Fang… - Nanoscale …, 2020 - pubs.rsc.org
Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases

Y Zhong, X Zeng, Y Zeng, L Yang, J Peng, L Zhao… - Nano Today, 2022 - Elsevier
Cardiovascular diseases refer to a group of the circulatory system disorders, including
atherosclerosis, thrombosis, myocardial/cerebral infarction and the following ischemia …

Nanoparticles as a novel platform for cardiovascular disease diagnosis and therapy

C Tang, K Zhou, D Wu, H Zhu - International Journal of …, 2024 - Taylor & Francis
Cardiovascular disease (CVD) is a major global health issue with high mortality and
morbidity rates. With the advances in nanotechnology, nanoparticles are receiving …

Nanomaterials as novel cardiovascular theranostics

R Pala, S Pattnaik, S Busi, SM Nauli - Pharmaceutics, 2021 - mdpi.com
Cardiovascular diseases (CVDs) are a group of conditions associated with heart and blood
vessels and are considered the leading cause of death globally. Coronary heart disease …

Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives

N Manners, V Priya, AK Mehata, M Rawat, S Mohan… - Pharmaceuticals, 2022 - mdpi.com
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Nanoparticles: Taking a unique position in medicine

TM Joseph, D Kar Mahapatra, A Esmaeili, Ł Piszczyk… - Nanomaterials, 2023 - mdpi.com
The human nature of curiosity, wonder, and ingenuity date back to the age of humankind. In
parallel with our history of civilization, interest in scientific approaches to unravel …

[HTML][HTML] Recent advances in the development of theranostic nanoparticles for cardiovascular diseases

Y Wu, KX Vazquez-Prada, Y Liu, AK Whittaker… - …, 2021 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …

Nanobased platform advances in cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering

L Shariati, Y Esmaeili, I Rahimmanesh… - Environmental …, 2023 - Elsevier
Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …